Munafa Stock Market Course + Intraday & FNO calls 
EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising
EMCURE NEWS reasons for why stock price of Emcure Pharmaceuticals L is falling or rising
EMCURE Emcure Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Emcure Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Emcure Pharmaceuticals EMCURE at this time. Stock is rising and might rise more.
It appears as if Emcure Pharmaceuticals EMCURE gave a large move recently.
Stock of Emcure Pharmaceuticals (EMCURE) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Emcure Pharmaceuticals is bullish for shortterm, and stock might move up till 1418.1 or till 1439.2. Use a stoploss of 1400.58 and if this stock hits its stoploss, then it can fall down till 1383.04
EMCURE Emcure Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2025-12-26
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about General Updates - NEWS as on 2025-12-24
Emcure Pharma launches second Novo drug for weight management Emcure Pharmaceuticals has taken a bold step in the realm of health and wellness by introducing Poviztra, a breakthrough in weight management. Developed by Danish biotech leader Novo Nordisk, Emcure proudly stands as the first Indian company to offer this - NEWS as on 2025-12-23 indiatimes.com
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2025, titled "Press Release titled Emcure Expands Weight Management Therapy Access with Launch of PoviztraŽ .". - NEWS as on 2025-12-22
Emcure Pharma launches weight loss drug Poviztra in India Emcure Pharmaceuticals has launched Poviztra, a semaglutide injection for weight loss, becoming the first Indian company to exclusively distribute Novo Nordisk's medication. Available in a once-weekly pen device, Poviztra is indicated for chronic weight ma - NEWS as on 2025-12-22 indiatimes.com
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 7700 securities pursuant to ESOP/ESPS at its meeting held on December 16, 2025 - NEWS as on 2025-12-17
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Schedule of meet - NEWS as on 2025-12-02
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed - NEWS as on 2025-11-27
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Chetan Sharma as Company Secretary & Compliance Officer of the company w.e.f. November 24, 2025. - NEWS as on 2025-11-24
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation - NEWS as on 2025-11-19
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of receipt of No-objection Letter for reclassification of shareholding from Promoter and Promoter Group category to Public category, in accordance with Regulation 31A of the - NEWS as on 2025-11-18
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2025-11-18
More announcements and NEWS
EMCURE Emcure Pharmaceuticals L current price & indicator signals
Recent prices of EMCURE Emcure Pharmaceuticals L are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 29 Mon Dec 2025 | 1404.00 | 1380.10 to 1442.40 | -1.68% | 1.5 times |
| 26 Fri Dec 2025 | 1428.00 | 1396.30 to 1442.00 | 1.2% | 0.96 times |
| 24 Wed Dec 2025 | 1411.10 | 1385.00 to 1465.00 | -1.08% | 2.28 times |
| 23 Tue Dec 2025 | 1426.50 | 1385.00 to 1430.00 | 3.44% | 0.91 times |
| 22 Mon Dec 2025 | 1379.10 | 1374.20 to 1405.00 | -0.43% | 1.07 times |
| 19 Fri Dec 2025 | 1385.00 | 1380.00 to 1406.10 | -0.2% | 0.39 times |
| 18 Thu Dec 2025 | 1387.80 | 1380.00 to 1394.40 | -0.29% | 0.3 times |
| 17 Wed Dec 2025 | 1391.90 | 1376.00 to 1400.00 | 0.76% | 0.67 times |
| 16 Tue Dec 2025 | 1381.40 | 1376.10 to 1395.30 | -1% | 0.91 times |
| 15 Mon Dec 2025 | 1395.40 | 1388.00 to 1438.60 | -3% | 0.92 times |
| 12 Fri Dec 2025 | 1438.60 | 1408.00 to 1469.00 | 2.08% | 1.59 times |
| 11 Thu Dec 2025 | 1409.30 | 1392.00 to 1419.90 | 0.01% | 0.29 times |
Videos related to: EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
